• Contact us
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you
Profit News Report
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
No Result
View All Result
Profit News Report
No Result
View All Result
Home Investing

Dow Jones slip 200 points as Trump Iran deadline fuels market fears

by
April 7, 2026
in Investing
0
Dow Jones slip 200 points as Trump Iran deadline fuels market fears
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Wall Street’s main indexes opened lower on Tuesday as investors assessed escalating tensions between the United States and Iran ahead of President Donald Trump’s deadline for Tehran to reopen the Strait of Hormuz.

The Dow Jones Industrial Average was down 214 points, or 0.46%, while the S&P 500 index fell 0.42% and the Nasdaq 100 declined 0.47%, reflecting growing unease about the trajectory of the conflict and its potential economic impact.

Geopolitical tensions weigh on sentiment

Investor sentiment weakened after reports of fresh military action and increasingly aggressive rhetoric from both sides.

A US official said in a Reuters report that the country had struck military targets on Iran’s Kharg Island, a key hub for the country’s oil exports, though no energy infrastructure was impacted.

Iran responded by signaling a more confrontational stance, saying it would no longer hold back from targeting infrastructure belonging to its Gulf neighbors.

The developments come ahead of Trump’s Tuesday deadline for Iran to reopen the Strait of Hormuz—one of the world’s most critical oil shipping routes. However, Tehran has shown no indication of complying. A senior Iranian source said in a Reuters report that talks on lasting peace could begin only after an end to the strikes.

Trump’s own remarks added to uncertainty. In a Truth Social post, he said: “A whole civilization will die tonight, never to be brought back again. I don’t want that to happen, but it probably will.”

He also left open the possibility of avoiding further escalation, adding that “now that we have Complete and Total Regime Change, where different, smarter, and less radicalized minds prevail, maybe something revolutionarily wonderful can happen, WHO KNOWS?”

Oil prices surge, complicating inflation outlook

Rising geopolitical risk pushed energy prices higher, adding another layer of concern for investors. West Texas Intermediate crude futures climbed more than 2% to above $115 per barrel, while Brent crude advanced about 1% to above $111.

The spike in oil prices has raised questions about inflationary pressures at a time when the Federal Reserve is navigating a complex economic backdrop.

The ongoing conflict has complicated the interest rate outlook, as policymakers weigh the risk of renewed inflation against a still-resilient labor market.

This week, investors are expected to closely monitor upcoming inflation data to assess whether elevated crude prices are feeding into broader price pressures.

Health insurers rally on policy boost

Despite the broader market weakness, healthcare stocks provided a bright spot after the US government announced an increase in Medicare Advantage payment rates for 2027.

Shares of UnitedHealth Group rose about 8%, while Humana gained 7.4% and CVS Health added 5.1%.

The policy change, which raises payments by an average of 2.48%, is expected to improve the earnings outlook for insurers and offset some of the broader market pressure.

Meanwhile, chipmaker Broadcom gained 3.8% after announcing a long-term agreement with Alphabet’s Google to develop artificial intelligence chips and related components.

Wall Street’s main indexes had closed higher on Monday, with the S&P 500 and Nasdaq notching a fourth consecutive session of gains.

However, the benchmark S&P 500 remains about 4% lower since the Middle East conflict began, highlighting the continued sensitivity of markets to geopolitical developments.

The post Dow Jones slip 200 points as Trump Iran deadline fuels market fears appeared first on Invezz

Previous Post

UBS cuts S&P 500 2026 targets amid rising oil prices

Next Post

Goldman Sachs flags Big Tech buy as Iran war dents valuations

Next Post
Goldman Sachs flags Big Tech buy as Iran war dents valuations

Goldman Sachs flags Big Tech buy as Iran war dents valuations

  • Trending
  • Comments
  • Latest
Trump’s Fed Criticism Sparks Investor Concerns

Trump’s Fed Criticism Sparks Investor Concerns

April 22, 2025
A look back at Biden’s Remarkable 50-year career in politics

A look back at Biden’s Remarkable 50-year career in politics

March 20, 2025
Fed’s Stagflation Warning Impacts Crypto Markets

Fed’s Stagflation Warning Impacts Crypto Markets

April 21, 2025
Gold Price Surge Hits $3,385 Amid Trade Tensions

Gold Price Surge Hits $3,385 Amid Trade Tensions

April 21, 2025
Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?

Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?

0
Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

0
The dollar index continues to pull back to a new low

The dollar index continues to pull back to a new low

0
BNGO Stock: BioNano Genomics Analysis and Forecast

BNGO Stock: BioNano Genomics Analysis and Forecast

0
Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?

Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?

April 7, 2026
Josh Brown names top travel stocks poised to weather geopolitical risks

Josh Brown names top travel stocks poised to weather geopolitical risks

April 7, 2026
Dem Senate primary erupts in key state as candidate teams up with radical streamer: ‘America deserved 9/11’

Dem Senate primary erupts in key state as candidate teams up with radical streamer: ‘America deserved 9/11’

April 7, 2026
Trump-backed candidate aims to pad GOP’s fragile House majority battle in showdown for MTG’s seat

Trump-backed candidate aims to pad GOP’s fragile House majority battle in showdown for MTG’s seat

April 7, 2026

Recent News

Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?

Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?

April 7, 2026
Josh Brown names top travel stocks poised to weather geopolitical risks

Josh Brown names top travel stocks poised to weather geopolitical risks

April 7, 2026
Dem Senate primary erupts in key state as candidate teams up with radical streamer: ‘America deserved 9/11’

Dem Senate primary erupts in key state as candidate teams up with radical streamer: ‘America deserved 9/11’

April 7, 2026
Trump-backed candidate aims to pad GOP’s fragile House majority battle in showdown for MTG’s seat

Trump-backed candidate aims to pad GOP’s fragile House majority battle in showdown for MTG’s seat

April 7, 2026
  • Contact us
  • Terms & Conditions
  • Privacy Policy
  • Contact us
  • Terms & Conditions
  • Privacy Policy

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com

No Result
View All Result
  • Contact us
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com